It’s a tested approach that helps build your business, supports the confidence of potential investors, and introduces your vision to the many potential partners, capital sources, mentors, clients, and allies within our Circle of BENefits.

Is a technology-focused business located in or with significant business presence in Philadelphia, Bucks, Chester, Delaware, or Montgomery counties
Can prove substantial technological differentiation with strong growth potential, sound corporate governance, and financial management
Can match Ben Franklin’s investment with capital from other sources—with funding from other investors, VCs, grants, friends and family, or other sources
We focus on Healthcare and Technology companies:
Barthalomew Sillah, MD, MBA
Kola Global
David Wierz, MA-ABD
Exponent
Karen Roggeman, MBA
KJR Advisory, LLC
Karen Roggeman is a seasoned biopharmaceutical executive who built her career at the multinational companies Merck & Co., Inc. and Boehringer Ingelheim, where she held senior leadership roles across the United States, France, and Germany.
John Patrick Dougherty, MBA
WindMIL Therapeutics
Scott Fishman
Envisage
Scott Fishman has over 30 years of experience as a life science strategist across all sectors of the industry focusing on healthcare marketing research and commercial analysis. s. As CEO of Research by Design, a firm he founded in 1989, Scott directed the evolution of the company from a bedroom startup to one of the most successful and prominent firms in the healthcare research industry.
Aaron Goldmuntz, MBA
Center for Medical Interoperability
Stuart Segal
Behavioral Health Executive
Allan Shatzman, Ph.D.
Pharmaceutical and Biotechnology Industry Expert
Gretchen L. Temeles, JD, Ph.D.
Lipton Weinberger & Busick
Catherine Unruh
Medical Synergy and Innovation, Inc.
Samuel Edland, MS
Optum
Jeannie Rojas, PhD MBA
GSK
Jeannie Rojas is Sr. Director of Worldwide Business Development at GSK. As a deal transactor, she focuses on closing deal across all GSK therapeutic areas.
Heather A Steinman, PhD, MBA
The Wistar Institute
Kate Cantera
Pivot Ventures
Samantha Jouin
Way Forward Advisory LLC
Troy Wilford
Keystone Life Sciences
Brandi Baldwin, Ed.D.
Millennial Ventures Holding Co.
Philip Bronner
Ardent Venture Capital
Ryan Caplan
Trovir
Eric Chapman
SustainVC
Bob Ciaruffoli
Baker Tilly Capital
Serhad Doken
Verizon
Sean Dowling
Osage Venture Partners
Holly Flanagan
Gabriel Investments
Frederik Groce
Storm Ventures
Lori Hardwick
Advisors Innovations Labs
Joseph Herbst
Innovative Financing Solutions
Kevin Kemmerer
Dude Solutions
Dave Kurtz
KMS Capital Group
Shoshana K Loeb, Ph.D.
Open Ventures
Kevin Marc Leonard
MissionOG
Amul Mago
Amazon Web Services
Mark A. Mitchell
Pennswood Capital
Philip Moyer
Google
David Nevas
Edison Partners
Katherine O’Neill
Jumpstart NJ Angel Network
Mark Mitchell
Delaware Crossing
Jordan DiPietro
Motley Fool
Pardon Makumbe
CRE Venture Capital
David Oppenheimer
Robin Hood Ventures
Doc Parghi
SRI Capital
Travis Pierce
Vanguard
Sushma Rajagopalan
Rittenhouse Ventures
Tom Rowinski
JTR Solutions
Neal Shah
InterDigital Communications
Evan Solomon
EFS Networks, Inc.
Nate Bomberger
Najabu Technologies
Leonid Kravets
InterDigital Communications
Jayson Tischler
Waterfall Advisory LLC
Neill Wright
Bronze Valley
Every business shapes its own unique path. However, key milestones will include the following sequence of touchpoints. As a Ben Franklin portfolio company, your path to investment will include opportunities to:
Sign up for our newsletter.
